| Product Unit Size | Cost | Quantity | Stock |
|---|
Phenethyl dimethyl caffeate (PEDMC) exhibits antiviral and immunomodulatory potential. Similar compounds display potential anticancer benefit as well. In vitro and in vivo, this compound may inhibit replication of HIV; it also increases levels of IL-2, IL-4, and IFN-γ.
| Cas No. | 145551-14-0 |
|---|---|
| Purity | ≥98% |
| Formula | C19H20O4 |
| Formula Wt. | 312.37 |
| Synonym | Caffeic Acid, Dimethyl Phenethyl Ester |
| Melting Point | 97-98°C |
| Solubility | Soluble in DMSO. |
| Store Temp | Ambient |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Ho CC, Lin SS, Chou MY, et al. Effects of CAPE-like compounds on HIV replication in vitro and modulation of cytokines in vivo. J Antimicrob Chemother. 2005 Aug;56(2):372-9. PMID: 16002419.
Lee YJ, Liao PH, Chen WK, et al. Preferential cytotoxicity of caffeic acid phenethyl ester analogues on oral cancer cells. Cancer Lett. 2000 May 29;153(1-2):51-6. PMID: 10779629.